Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 11,159 | 9,994 | 34,477 | 13,851 | 9,598 |
| Gross Profit | 11,159 | 9,994 | 34,477 | 13,851 | 9,598 |
| Operating Expenses | 159,503 | 176,610 | 150,536 | 120,250 | 76,577 |
| Operating Income | -148,344 | -166,616 | -116,059 | -106,399 | -66,979 |
| Other Income | -331 | 17,502 | 14,182 | 7,048 | 377 |
| Pre-tax Income | -148,675 | -149,114 | -101,877 | -99,351 | -66,602 |
| Income Tax | -550 | -9 | 193 | 70 | 321 |
| Net Income Continuous | -148,125 | -149,105 | -102,070 | -99,421 | -66,923 |
| Net Income | $-148,125 | $-149,105 | $-102,070 | $-99,421 | $-66,923 |
| EPS Basic Total Ops | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| EPS Basic Continuous Ops | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| EPS Diluted Total Ops | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| EPS Diluted Continuous Ops | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| EPS Diluted Before Non-Recurring Items | -1.36 | -1.65 | -1.38 | -1.64 | -2.11 |
| EBITDA(a) | $-145,839 | $-167,415 | $-116,959 | $-105,574 | $-65,943 |